Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / AGLE - Aeglea BioTherapeutics appoints Linda Neuman as chief medical officer


AGLE - Aeglea BioTherapeutics appoints Linda Neuman as chief medical officer

  • Aeglea BioTherapeutics ( NASDAQ: AGLE ) said on Tuesday it had appointed Linda Neuman as the chief medical officer.
  • Neuman's appointment is an internal promotion from her previous role as Aeglea's senior vice president of clinical development.
  • Before Aeglea, Neuman served as vice president, clinical development at Catalyst Biosciences where she led the clinical development of their late-stage development program for a novel hemophilia treatment.

For further details see:

Aeglea BioTherapeutics appoints Linda Neuman as chief medical officer
Stock Information

Company Name: Aeglea BioTherapeutics Inc.
Stock Symbol: AGLE
Market: NASDAQ
Website: aegleabio.com

Menu

AGLE AGLE Quote AGLE Short AGLE News AGLE Articles AGLE Message Board
Get AGLE Alerts

News, Short Squeeze, Breakout and More Instantly...